EU regulator reviews reports of rare nervous disorder after AstraZeneca vaccine


Bywire - Claim your free account nowBywire - Claim your free account now

- Europe's medicines regulator said on Friday it was reviewing reports of a rare condition affecting the nerves following vaccination with AstraZeneca's COVID-19 shot, and requested the British drugmaker for more detailed data.

As part of a regular review of safety reports for the vaccine, Vaxzevria, the European Medicines Agency's safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.

AstraZeneca did not immediately respond to requests for comment.

(Reporting by Pushkala Aripaka in Bengaluru and Ludwig Burger in Frankfurt; Editing by Shinjini Ganguli)

Bywire will email you from time to time with news digests, stories & opportunities to get involved. Privacy

Bywire - Claim your free account nowBywire - Claim your free account now